WHITE PINE CAPITAL LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.

Quarter-by-quarter ownership
WHITE PINE CAPITAL LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$367,000
+32.5%
1,3380.0%0.13%
+31.3%
Q2 2018$277,000
-75.1%
1,338
-80.1%
0.10%
-75.9%
Q1 2018$1,112,000
+13.0%
6,733
-6.3%
0.41%
+13.9%
Q4 2017$984,000
+0.9%
7,183
+0.3%
0.36%
+17900.0%
Q3 2017$975,000
+8.0%
7,158
-3.8%
0.00%
-99.4%
Q2 2017$903,000
+13.2%
7,438
-1.3%
0.36%
+9.9%
Q1 2017$798,000
+4.0%
7,538
-0.2%
0.32%
-0.3%
Q4 2016$767,000
-0.5%
7,5500.0%0.32%
-1.2%
Q3 2016$771,000
-21.2%
7,550
-7.9%
0.33%
-20.1%
Q2 2016$978,000
-14.1%
8,200
-22.8%
0.41%
-15.4%
Q1 2016$1,138,000
-2.8%
10,625
-1.7%
0.49%
-6.0%
Q4 2015$1,171,000
+24.6%
10,805
-1.6%
0.52%
+18.8%
Q3 2015$940,000
-18.7%
10,980
-4.1%
0.44%
-11.9%
Q2 2015$1,156,000
-5.7%
11,455
-28.0%
0.50%
-0.4%
Q1 2015$1,226,000
+53.2%
15,905
+5.8%
0.50%
+84.8%
Q4 2014$800,000
+42.1%
15,030
+25.5%
0.27%
+40.1%
Q3 2014$563,000
-10.1%
11,975
+19.2%
0.19%
+68.4%
Q2 2014$626,000
-7.4%
10,0500.0%0.11%
-6.6%
Q1 2014$676,000
-54.3%
10,050
-64.3%
0.12%
-55.5%
Q4 2013$1,480,000
+13.5%
28,150
-6.6%
0.27%
+16.1%
Q3 2013$1,304,000
-32.0%
30,150
-41.1%
0.24%0.0%
Q2 2013$1,917,00051,2250.24%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
BVF INC/IL 2,626,160$138,136,00024.17%
KNOTT DAVID M 1,292,566$67,988,972,00013.87%
GROW Partners, LLC 200,000$10,520,0006.41%
Opaleye Management Inc. 90,000$4,860,000,0003.82%
OBERWEIS ASSET MANAGEMENT INC/ 213,317$11,220,0002.72%
First Light Asset Management, LLC 60,242$3,169,0002.69%
Timpani Capital Management LLC 98,956$5,205,0002.59%
Iguana Healthcare Management, LLC 75,000$3,945,0002.25%
Eventide Asset Management 134,400$7,069,0002.18%
ASHFORD CAPITAL MANAGEMENT INC 215,223$11,321,0002.16%
View complete list of LIGAND PHARMACEUTICALS INC shareholders